Uniform procedure of (1)H NMR analysis of rat urine and toxicometabonomics Part II: comparison of NMR profiles for classification of hepatotoxicity.
暂无分享,去创建一个
A. Tas | M. Smit | J. Vogels | P. Zandberg | J. H. V. Van Nesselrooij | C. Kloks | W. Schoonen | Jack T W E Vogels | Willem G E J Schoonen | G Jean Horbach | Joop H J van Nesselrooij | J. Ploemen | G. Horbach | J. Mellema | Carol Thijssen-Vanzuylen | Albert C Tas | Cathelijne P A M Kloks | Jan-Peter H T M Ploemen | Martin J Smit | Pieter Zandberg | Jan-Remt Mellema | Carol Thijssen-Vanzuylen | J. H. V. van Nesselrooij
[1] C. Rae,et al. 1H NMR spectroscopic survey of plasma and erythrocytes from selected marsupials and domestic animals of Australia. , 1991, Comparative biochemistry and physiology. B, Comparative biochemistry.
[2] E Holmes,et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.
[3] G. Pozzato,et al. Prevention of S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women. , 1988, The American journal of gastroenterology.
[4] Hisham K. Hamadeh,et al. Toxicogenomics : principles and applications , 2005 .
[5] C. Gartung,et al. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. , 1996, The American journal of physiology.
[6] Procrustes rotation and pair-wise correlation: A parametric and a non-parametric method for variable selection , 2004 .
[7] Pedro Cuatrecasas,et al. Drug discovery in jeopardy. , 2006, The Journal of clinical investigation.
[8] J. Lindon,et al. Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.
[9] R. Niesink,et al. Toxicology: Principles and Applications , 1996 .
[10] J H Lewis,et al. Drug-induced liver disease. , 2000, Clinics in liver disease.
[11] T. Fan. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures , 1996 .
[12] John C. Lindon,et al. Metabonomics Techniques and Applications to Pharmaceutical Research & Development , 2006, Pharmaceutical Research.
[13] R. Melchert,et al. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. , 1995, Journal of pharmacological and toxicological methods.
[14] Esther F. Schmid,et al. Drug withdrawals and the lessons within. , 2006, Current opinion in drug discovery & development.
[15] I. Murray-Lyon,et al. LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE , 1977, The Lancet.
[16] V. Govindaraju,et al. Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.
[17] E Holmes,et al. Development of a model for classification of toxin‐induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition , 1998, NMR in biomedicine.
[18] Donald G Robertson,et al. Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[19] V. Vollrath,et al. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. , 1996, Journal of hepatology.
[20] J. Ribalta,et al. Sulfobromophthalein clearance tests before and after ethinyl estradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. , 1981, Gastroenterology.
[21] Jürgen Borlak. Handbook of toxicogenomics : strategies and applications , 2005 .
[22] Elaine Holmes,et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. , 2005, Pharmacogenomics.
[23] C. Gopinath,et al. Atlas of Experimental Toxicological Pathology , 1987, Current Histopathology.
[24] M. Sleisenger,et al. Idiopathic cholestasis of pregnancy. , 1967 .
[25] D. Ritchie,et al. The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. , 2001, Current topics in medicinal chemistry.
[26] John C. Lindon,et al. Detection of in vivo biomarkers of phospholipidosis using NMR‐based metabonomic approaches , 2001 .
[27] C. Ronco,et al. Reviews: Uremic Toxins: A New Focus on an Old Subject , 2005, Seminars in dialysis.
[28] Ben van Ommen,et al. Profiles of Metabolites and Gene Expression in Rats with Chemically Induced Hepatic Necrosis , 2005, Toxicologic pathology.
[29] E Holmes,et al. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: A metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[30] B. Car,et al. Metabonomics: Application in Predictive and Mechanistic Toxicology , 2004 .
[31] K. Ishak,et al. Hepatotoxic Effects of the Anabolic/Androgenic Steroids1 , 1987, Seminars in liver disease.
[32] Elaine Holmes,et al. Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.
[33] D. Baunsgaard,et al. Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in Rats and to identify potential biomarkers , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[34] J. Timbrell,et al. Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. , 1978, The Journal of pharmacology and experimental therapeutics.
[35] M. Reily,et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[36] S. Gatley,et al. The synthesis of hippurate from benzoate and glycine by rat liver mitochondria. Submitochondrial localization and kinetics. , 1977, The Biochemical journal.
[37] V. Catania,et al. Ursodeoxycholate Reduces Ethinylestradiol Glucuronidation in the Rat: Role in Prevention of Estrogen-Induced Cholestasis , 2003, Journal of Pharmacology and Experimental Therapeutics.
[38] J. Trygg,et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. , 2005, Analytical chemistry.
[39] Jeremy K Nicholson,et al. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. , 2004, Chemical research in toxicology.
[40] A. Elfarra,et al. Species and tissue differences in the toxicity of 3-butene-1,2-diol in male Sprague-Dawley rats and B6C3F1 mice. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[41] J. Timbrell,et al. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. , 1976, Science.
[42] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[43] J. Lindon,et al. NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.
[44] C. Laggner,et al. Why drugs fail--a study on side effects in new chemical entities. , 2005 .
[45] D. N. Gupta. Acute changes in the liver after administration of thioacetamide. , 1956, The Journal of pathology and bacteriology.
[46] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[47] C. Figueroa,et al. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver. , 1995, Journal of hepatology.
[48] J. van der Greef,et al. Partial linear fit: A new NMR spectroscopy preprocessing tool for pattern recognition applications , 1996 .
[49] A. Tas,et al. Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: dose-dependent toxic effects of bromobenzene and paracetamol. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[50] J. Griffin. The potential of metabonomics in drug safety and toxicology. , 2004, Drug discovery today. Technologies.